Representative Matters

Decisive Legal Outcomes

A selection of high-stakes dossiers demonstrating our institutional authority in corporate strategy and intellectual property defense.

CorporateCross-Border Tech Acquisition
Software Infrastructure6-Month Closing

Regulatory Obstacle

Complex multi-jurisdictional antitrust review threatened to stall a $450M acquisition, risking significant market share loss and investor confidence.

"Lexcor navigated the regulatory landscape with precision, ensuring our acquisition closed without operational disruption."

— Sarah J., General Counsel at TechCorp

Firm Strategy

Executed a comprehensive regulatory compliance strategy, proactively addressing competition concerns through targeted divestiture and governance restructuring.

Proactive engagement with federal regulators
Streamlined cross-border asset transfer
Rigorous post-merger compliance framework

Matter Valuation

Regulatory ApprovalFast

Cleared 3 months ahead of schedule

Deal Value$450M

Successfully closed acquisition

Risk Reduction95%

Mitigated litigation exposure

Secure Consultation
IP LawPatent Infringement Defense
Biotech Research14-Month Trial

Litigation Threat

A major competitor filed a patent infringement suit targeting our core diagnostic technology, threatening to halt production and invalidate our IP portfolio.

"Lexcor provided the technical and legal expertise required to protect our most valuable intellectual property assets."

— Dr. Alan R., CEO at BioDiagnostics

Firm Strategy

Developed a robust defense strategy focusing on prior art invalidation and technical expert testimony to secure a favorable summary judgment.

Comprehensive prior art discovery process
Strategic expert witness coordination
Successful summary judgment motion

Matter Valuation

Case OutcomeWon

Summary judgment in our favor

IP PortfolioSaved

Invalidation threat neutralized

Legal CostsLow

Avoided protracted trial expenses

Secure Consultation

Consultation Request

Engage our senior partners for a confidential assessment of your corporate or intellectual property matter.

Initiate Intake